https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-13 / Immunobiology 2006;211(6-8):677-85
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-13 / Immunobiology 2006;211(6-8):677-852006-07-13 00:00:002019-02-15 08:32:39Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / J. Neurosurg. 2006 Jul;105(1):41-502006-07-01 00:00:002019-02-15 09:00:00Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / Neurol. Res. 2006 Jul;28(5):527-312006-07-01 00:00:002019-02-15 09:00:01Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-07-01 / Curr Oncol Rep 2006 Jul;8(4):305-92006-07-01 00:00:002006-07-01 00:00:00The role of hyperthermia in combined treatment in the management of soft tissue sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-30 / Cell. Immunol. 2006 Feb;239(2):144-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-30 / Cell. Immunol. 2006 Feb;239(2):144-502006-06-30 00:00:002019-02-15 09:11:48Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-13 / Int. Immunol. 2006 Aug;18(8):1279-832006-06-13 00:00:002019-02-15 09:23:48Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-01 / Cancer Res. 2006 Jun;66(11):5910-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-01 / Cancer Res. 2006 Jun;66(11):5910-82006-06-01 00:00:002019-02-15 09:17:03Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-01 / Prostate 2006 Jun;66(8):811-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-01 / Prostate 2006 Jun;66(8):811-212006-06-01 00:00:002019-02-15 09:24:16Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-01 / Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006 Jun;31(3):350-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-01 / Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006 Jun;31(3):350-22006-06-01 00:00:002006-06-01 00:00:00[Therapeutic effect of whole body hyperthermia combined with chemotherapy in patients with advanced cancer]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-06-01 / Expert Opin Biol Ther 2006 Jun;6(6):591-604
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-06-01 / Expert Opin Biol Ther 2006 Jun;6(6):591-6042006-06-01 00:00:002006-06-01 00:00:00Dendritic cell immunotherapy for breast cancer
